- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07701980
Horizontal vs Vertical Scleral Tunnels in Flanged IOL Fixation (HORVER)
Horizontal Versus Vertical Scleral Tunnel Orientation in Flanged Intrascleral Fixation: A 2-Year Comparative Study
Studie Overzicht
Toestand
Interventie / Behandeling
Gedetailleerde beschrijving
Background: The management of aphakia, crystalline lens luxation, and intraocular lens (IOL) luxation in the absence of adequate capsular support remains challenging. Traditional surgical options include anterior chamber IOLs, iris-fixated IOLs, and scleral-sutured posterior chamber IOLs, each carrying significant long-term risks. In 2017, Yamane and colleagues introduced a sutureless flanged intrascleral IOL fixation technique that rapidly gained worldwide acceptance. A critical yet under-investigated surgical variable is the orientation of the scleral tunnels relative to the limbus. Some surgeons create tunnels parallel to the limbus (horizontal/tangential), others perpendicular (vertical/radial), based on personal preference rather than high-level evidence.
Objective: To evaluate whether horizontal versus vertical scleral tunnel orientation is associated with differing 2-year outcomes in flanged intrascleral IOL fixation.
Study Design: This is a retrospective observational cohort study conducted at a single tertiary referral centre.
Participants: A total of 107 eyes (43 vertical tunnels, 64 horizontal tunnels) with complete 24-month follow-up are included. Surgeries are performed by two experienced vitreoretinal surgeons.
Interventions: All procedures follow the original Yamane flanged intrascleral fixation method with intentional variation in tunnel orientation only. The horizontal tunnel group receives tunnels parallel to the limbus (tangential), while the vertical tunnel group receives tunnels perpendicular to the limbus (radial). A three-piece foldable acrylic IOL (Alcon AcrySof MA60AC) is used in all eyes.
Outcome Measures: The primary outcome is the proportion of eyes achieving mean absolute error (MAE) within ±0.50D of target refraction at 2 years. Secondary outcomes include MAE at 2 years, IOL tilt measured using anterior segment optical coherence tomography (AS-OCT), iris capture, conjunctival erosion, cystoid macular oedema, epiretinal membrane, retinal detachment, vitreous haemorrhage, hypotony, corneal oedema, early IOP elevation, best-corrected visual acuity (BCVA), and vector astigmatism analysis using the Alpins method.
Statistical Analysis: Propensity score matching (1:1) will be performed to address selection bias. Multivariate logistic regression and a multilevel mixed-effects model with surgeon as random effect will be used to adjust for confounders including surgical period, age, and baseline refraction. For the primary outcome, a single pre-specified comparison will be made with a two-tailed significance level of α = 0.05. For secondary outcomes, the False Discovery Rate (FDR) using the Benjamini-Hochberg procedure (q = 0.05) will be applied to control for Type I error inflation.
Timeline: Data were collected from patients who underwent surgery between March 1, 2022, and March 1, 2025. Minimum follow-up is 24 months, with final data collection completed in March 2025.
Studietype
Inschrijving (Werkelijk)
Contacten en locaties
Studie Locaties
-
-
-
Van, Turkije (Türkiye), 65000
- SBU Van Training and Research Hospital
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Bemonsteringsmethode
Studie Bevolking
Beschrijving
Inclusion Criteria:
- Age ≥ 18 years
- Complicated aphakia defined as absence of adequate capsular support following cataract extraction, lens trauma, or previous lensectomy
- Crystalline lens luxation defined as partial or complete displacement of the natural lens due to zonular weakness
- Intraocular lens (IOL) luxation defined as partial or complete dislocation of a previously implanted IOL
- Inadequate capsular support (<180° of intact zonular or capsular support)
- Ability to complete scheduled follow-up visits
- Complete follow-up data available
Exclusion Criteria:
- Previous scleral buckling surgery within 6 months
- Pars plana vitrectomy within 3 months
- Active uveitis
- Active endophthalmitis
- Uncontrolled scleritis or scleral thinning
- Corneal decompensation (endothelial cell density <1000 cells/mm²)
- Uncontrolled glaucoma (IOP >25 mmHg despite maximum therapy)
- History of penetrating keratoplasty, DALK, DSEK, or DMEK
- History of corneal refractive surgery
- Active proliferative diabetic retinopathy
- Pregnancy or breastfeeding
- Inability to complete 24-month follow-up
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
Cohorten en interventies
Groep / Cohort |
Interventie / Behandeling |
|---|---|
|
Vertical Scleral Tunnel Group
Patients who underwent flanged intrascleral IOL fixation with scleral tunnels created perpendicular to the limbus (radial/vertical orientation).
|
Sutureless flanged intrascleral fixation of a three-piece foldable acrylic IOL (Alcon AcrySof MA60AC).
Two partial-thickness scleral tunnels are created 2.0 mm posterior to the limbus, 180° apart.
Haptics are externalized through the tunnels, and a flange is created on each haptic tip using thermal cautery.
Tunnel orientation varied intentionally: horizontal (parallel to limbus) or vertical (perpendicular to limbus).
|
|
Horizontal Scleral Tunnel Group
Patients who underwent flanged intrascleral IOL fixation with scleral tunnels created parallel to the limbus (tangential/horizontal orientation).
|
Sutureless flanged intrascleral fixation of a three-piece foldable acrylic IOL (Alcon AcrySof MA60AC).
Two partial-thickness scleral tunnels are created 2.0 mm posterior to the limbus, 180° apart.
Haptics are externalized through the tunnels, and a flange is created on each haptic tip using thermal cautery.
Tunnel orientation varied intentionally: horizontal (parallel to limbus) or vertical (perpendicular to limbus).
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Proportion of Eyes Achieving Mean Absolute Error (MAE) Within ±0.50 Diopters of Target Refraction
Tijdsspanne: 24 Months
|
The proportion of eyes achieving mean absolute error (MAE) within ±0.50 diopters of the target spherical equivalent refraction at 24 months postoperatively.
|
24 Months
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Mean Absolute Error (MAE) at 2 Years
Tijdsspanne: 24 Months
|
Mean absolute error in spherical equivalent refraction at 24 months postoperatively.
|
24 Months
|
|
IOL Tilt Angle
Tijdsspanne: 24 Months
|
Intraocular lens tilt angle measured using anterior segment optical coherence tomography (AS-OCT) at 24 months postoperatively.
|
24 Months
|
Medewerkers en onderzoekers
Sponsor
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Andere studie-ID-nummers
- GOKAEK-2024-04-02 (Andere identificatie: Van Training and Research Hospital Ethics Committee)
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .